Salivary and serum nitric oxide synthase, macrophage inflammatory protein 1 alpha and macrophage migration inhibitory factor levels in periodontal disease

被引:0
作者
Oner, Fatma [1 ]
Onat, Faruk Cagri [2 ]
Karasu, Yerda Ozkan [2 ,3 ]
机构
[1] Bahcesehir Univ, Fac Dent Med, Dept Periodontol, Istanbul, Turkiye
[2] Ataturk Univ, Fac Dent & Med, Dept Periodontol, Erzurum, Turkiye
[3] Ataturk Univ, Fac Dent Med, Dept Periodontol, TR-25200 Yakutiye Erzurum, Turkiye
关键词
Gingivitis; iNOS; MIP-1; alpha; MIF; Periodontitis; PERI-IMPLANT DISEASES; 2017 WORLD WORKSHOP; CONSENSUS REPORT; MIP-1-ALPHA; EXPRESSION; BIOMARKERS; MIF; CLASSIFICATION; CONTRIBUTES; IMMUNITY;
D O I
10.1016/j.heliyon.2024.e25888
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objective: Periodontal disease is multifactorial inflammatory disease involving both gingivitis and periodontitis. Inducible nitric oxide synthase (iNOS), macrophage inflammatory protein 1 alpha (MIP-1 alpha) and macrophage migration inhibitory factor (MIF) are mediators contributing to the progression of periodontal diseases with distinct functions. The aim of this study is to evaluate the local and systemic iNOS, MIP-1 alpha and MIF concentrations in patients having periodontal disease with different severities. Design: The study was conducted on 88 individuals equally divided into four groups; 1) Periodontally Healthy 2) Gingivitis 3) Stage I-II Periodontitis 4) Stage III-IV Periodontitis. Saliva and serum samples were obtained from each individual and then periodontal examinations were performed. Plaque and bleeding on probing indexes, probing depths and clinical attachment levels were measured on each tooth to determine the periodontal status. Concentrations of iNOS, MIP-1 alpha and MIF were measured with enzyme -linked immunosorbent assay. Results: Patients with stage I-II and stage III-IV periodontitis had more iNOS levels than periodontally healthy people in serum and saliva (p <= 0,001 for serum; p < 0,05 for saliva). Stage III-IV periodontitis group had significantly more serum-iNOS levels than that in gingivitis group (p = 0,005). When compared with periodontally healthy individuals, MIP-1 alpha levels in stage III-IV periodontitis patients were measured significantly more in saliva; (p = 0,016) but less in serum (p = 0,006) samples. More serum-MIF concentrations were observed in stage I-II periodontitis groups than that in periodontally healthy individuals (p < 0,05). Conclusion: Increased salivary and serum iNOS and serum-MIF levels in different stages of periodontitis suggest that these molecules might be involved in periodontal disease pathogenesis. Also, oral microenvironment may stimulate the enhanced MIP-1 alpha concentration in advanced periodontitis cases.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Susceptibility to Inflammatory Coronary Heart Disease
    Ji, Kangting
    Wang, Xiaoyan
    Li, Ji
    Lu, Qin
    Wang, Guoqiang
    Xue, Yangjing
    Zhang, Suqin
    Qian, Lu
    Wu, Wenwu
    Zhu, Yongjin
    Wang, Luping
    Liao, Lianming
    Tang, Jifei
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [22] Macrophage Migration Inhibitory Factor in Normal Human Skeletal Muscle and Inflammatory Myopathies
    Reimann, Jens
    Schnell, Susanne
    Schwartz, Stephanie
    Kappes-Horn, Karin
    Dodel, Richard
    Bacher, Michael
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2010, 69 (06) : 654 - 662
  • [23] Involvement of macrophage migration inhibitory factor in the pathogenesis of idiopathic orbital inflammatory pseudotumor
    Zhao, Pengxiang
    Ma, Jianmin
    Shang, Lei
    Mawulikplimi, Adzavon Yao
    Wang, Xiaoyue
    Wu, Yanan
    Xie, Fei
    Chen, Danying
    Yang, Linqi
    Li, Qinjian
    Ma, Xuemei
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 6659 - 6671
  • [24] Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease
    Yuksel, Arif
    Bilgir, Ferda
    Bilgir, Oktay
    Calan, Mehmet
    Bozkaya, Giray
    CLINICS, 2015, 70 (03) : 169 - 172
  • [25] Elevated Serum Macrophage Migration Inhibitory Factor Levels in Post-operative Biliary Atresia
    Nattee, Papit
    Honsawek, Sittisak
    Chongsrisawat, Voranush
    Vejchapipat, Paisarn
    Thamboonlers, Apiradee
    Poovorawan, Yong
    ASIAN JOURNAL OF SURGERY, 2009, 32 (02) : 109 - 113
  • [26] Macrophage Inflammatory Protein-1α: A Salivary Biomarker of Bone Loss in a Longitudinal Cohort Study of Children at Risk for Aggressive Periodontal Disease?
    Fine, Daniel H.
    Markowitz, Kenneth
    Furgang, David
    Fairlie, Karen
    Ferrandiz, Javier
    Nasri, Cebile
    McKiernan, Marie
    Donnelly, Robert
    Gunsolley, John
    JOURNAL OF PERIODONTOLOGY, 2009, 80 (01) : 106 - 113
  • [27] Serum macrophage migration inhibitory factor levels predict brain atrophy in people with primary progressive multiple sclerosis
    Ladakis, Dimitrios C.
    Reyes-Mantilla, Maria, I
    Gadani, Sachin P.
    Mace, Jackson W.
    Dominguez-Penuela, Susana C.
    Appiah, Mayaa J.
    Smith, Matthew D.
    Bhargava, Pavan
    Fox, Robert J.
    Saidha, Shiv
    Calabresi, Peter A.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (01) : 35 - 43
  • [28] The clinical signature of genetic variants and serum levels of macrophage migration inhibitory factor in Egyptian breast cancer patients
    Seliem, Mahmoud A.
    Mohamadin, Ahmed M.
    El-Sayed, Mohamed I. Kotb
    Ismail, Yahia
    El-Husseiny, Ahmed A.
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 208 (01) : 57 - 66
  • [29] Novel Anti-inflammatory Activity of Epoxyazadiradione against Macrophage Migration Inhibitory Factor INHIBITION OF TAUTOMERASE AND PROINFLAMMATORY ACTIVITIES OF MACROPHAGE MIGRATION INHIBITORY FACTOR
    Alam, Athar
    Haldar, Saikat
    Thulasiram, Hirekodathakallu V.
    Kumar, Rahul
    Goyal, Manish
    Iqbal, Mohd Shameel
    Pal, Chinmay
    Dey, Sumanta
    Bindu, Samik
    Sarkar, Souvik
    Pal, Uttam
    Maiti, Nakul C.
    Bandyopadhyay, Uday
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (29) : 24844 - 24861
  • [30] Investigation of serum macrophage migration inhibitor factor and monocyte chemotactic protein-1 levels in irritable bowel syndrome
    Tulubas, Feti
    Oran, Mustafa
    Mete, Rafet
    Turan, Filiz
    Yilmaz, Ahsen
    Yildiz, Zeynep Deniz
    Gurel, Ahmet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2014, 44 (06) : 967 - 971